Capricor Therapeutics (CAPR) Intangibles (2012 - 2021)
Capricor Therapeutics' (CAPR) quarterly Intangibles came in at $1083.0 in Q1 2021, down 79.99% year-on-year from $5413.0 in Q1 2020, and down 49.98% quarter-over-quarter from $2165.0 in Q4 2020.
Capricor Therapeutics (CAPR) Intangibles (2012 - 2021) Analysis & Trends
Capricor Therapeutics' Intangibles history runs 10 years deep, the most recent figure standing at $1083.0 for Q1 2021.
- On a quarterly basis, Intangibles fell 79.99% year-over-year to $1083.0 in Q1 2021; TTM through Mar 2021 was $1083.0, a 79.99% decrease from a year earlier, with the FY2020 full-year figure at $2165.0, down 66.67% from the prior year.
- Intangibles fell to $1083.0 in Q1 2021 per CAPR's latest filing, from $2165.0 in the prior quarter.
- Across five years, Intangibles topped out at $130066.0 in Q1 2017 and bottomed at $1083.0 in Q1 2021.
- The 5-year median for Intangibles is $38952.0 (2019), against an average of $48107.1.
- Biggest YoY gain for Intangibles was 31.56% in 2017; the steepest drop was 92.14% in 2017.
- Year by year, Intangibles stood at $93048.0 in 2017, then sank by 46.51% to $49772.0 in 2018, then tumbled by 86.95% to $6495.0 in 2019, then sank by 66.67% to $2165.0 in 2020, then plunged by 49.98% to $1083.0 in 2021.
- Per Business Quant, the three latest CAPR Intangibles figures stand at $1083.0 (Q1 2021), $2165.0 (Q4 2020), and $3248.0 (Q3 2020).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | Capricor Therapeutics | 457.86 Mn | 457.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 1,083.00 |
| Dec 31, 2020 | 2,165.00 |
| Sep 30, 2020 | 3,248.00 |
| Jun 30, 2020 | 4,330.00 |
| Mar 31, 2020 | 5,413.00 |
| Dec 31, 2019 | 6,495.00 |
| Sep 30, 2019 | 17,314.00 |
| Jun 30, 2019 | 28,133.00 |
| Mar 31, 2019 | 38,952.00 |
| Dec 31, 2018 | 49,772.00 |
| Sep 30, 2018 | 60,591.00 |
| Jun 30, 2018 | 71,410.00 |
| Mar 31, 2018 | 82,229.00 |
| Dec 31, 2017 | 93,048.00 |
| Sep 30, 2017 | 105,692.00 |
| Jun 30, 2017 | 117,879.00 |
| Mar 31, 2017 | 130,066.00 |
| Dec 31, 2016 | 142,253.00 |
| Sep 30, 2016 | 154,441.00 |
| Jun 30, 2016 | 1.50 Mn |